AN ADJUNCTIVE MANAGEMENT OF DEPRESSION PROGRAM FOR DIFFICULT-TO-TREAT DEPRESSED PATIENTS AND THEIR FAMILIES

被引:11
|
作者
Ryan, Christine E.
Keitner, G. I. [1 ]
Bishop, S.
机构
[1] Rhode Isl Hosp, Mood Disorders Program, Providence, RI 02903 USA
关键词
depression; mood disorders; family functioning; psychosocial functioning; quality of life; REFRACTORY DEPRESSION; PSYCHOTHERAPY; SYMPTOMS; UNIPOLAR; OUTCOMES; THERAPY; MODEL; CARE;
D O I
10.1002/da.20640
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: The goal of this open-label feasibility trial was to test a short-term, adjunctive intervention, the Management of Depression (MoD) Program, to determine if patients with difficult-to-treat forms of depression and their family members could learn to cope more effectively with their illness. Methods: Nineteen patients meeting The Diagnostic and Statistical Manual TV criteria for major depressive disorder, dysthymia, or chronic/recurrent depression and their family members participated in an open-label study testing the efficacy of the MoD Program. The intervention consisted of nine sessions over 16 weeks, followed by an 8-month maintenance phase. Outcome measures focused on quality of life, psychological and family functioning, and level of depression. Results: Fourteen patients and their family members improved significantly in psychosocial, and family functioning, and depression severity (all P-values <.05) by the end of the 16-week intervention. There was also significant improvement in quality of life, psychosocial and family functioning, and depression scores (all P-values <.05) for the 10 patients who completed the maintenance phase. Conclusion The MoD Program is a useful adjunctive intervention that helped patients and their family members deal more effectively with their persisting depression. The disease management approach improved the patient's perceived quality of life and functioning, reduced depressive symptoms, and improved perception of their family's functioning. Depression and Anxiety 27:27-34, 2010. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 50 条
  • [1] Management of difficult-to-treat depression with anxiety
    Papakostas, George
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 324 - 324
  • [2] Difficult-to-Treat depression
    Kupfer, DJ
    Charney, DS
    [J]. BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 633 - 634
  • [3] Difficult-to-treat depression
    Castle, David J.
    Piterman, Leon
    Berk, Michael
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2013, 199 (06) : 4 - 5
  • [4] Predicting treatment outcome in difficult-to-treat depressed patients
    Camardese, G.
    Mosca, L.
    Picello, A.
    Morelli, C.
    Adamo, E.
    Pucci, L.
    Mattioli, B.
    Bria, P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S326 - S327
  • [5] Management of difficult-to-treat inhibitor patients
    Giangrande, P. L. F.
    Escobar, M. A.
    [J]. HAEMOPHILIA, 2010, 16 : 52 - 57
  • [6] Thoughtful prescribing for patients with difficult-to-treat depression
    Soubolsky, Amy
    Visentin, Jessica
    Crawley, Alex
    [J]. CANADIAN FAMILY PHYSICIAN, 2023, 69 (11) : E221 - E228
  • [7] Pharmacologic management of difficult-to-treat depression in clinical practice
    Fleck, MP
    Horwath, E
    [J]. PSYCHIATRIC SERVICES, 2005, 56 (08) : 1005 - 1011
  • [8] The management of patients with difficult-to-treat multiple myeloma
    Richter, Joshua
    Ramasamy, Karthik
    Rasche, Leo
    Blade, Joan
    Zweegman, Sonja
    Davies, Faith
    Dimopoulos, Meletios
    [J]. FUTURE ONCOLOGY, 2021, 17 (16) : 2089 - 2105
  • [9] Fast titration of adjunctive topiramate in paediatric patients with difficult-to-treat epilepsy
    Kluger, G.
    Schreiner, A.
    Schauble, B.
    Holthausen, H.
    [J]. EPILEPSIA, 2006, 47 : 184 - 184
  • [10] An inflamed subtype of difficult-to-treat depression
    Suneson, Klara
    Grudet, Cecile
    Ventorp, Filip
    Malm, Johan
    Asp, Marie
    Westrin, Asa
    Lindqvist, Daniel
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2023, 125